Summary.
Two categories of cell death related to antigens, apogens and engulfens, have been reported to be expressed by apoptotic cells and the cells involved in their engulfment in the immune system, and in mesenchymal tissue in the limb of the chick embryo (RoTTELLo et al., 1994) . To determine whether these antigens are also expressed during the process of neuronal death, the distribution of immunoreactivity to both anti-apogen and anti-engulfen antibodies was examined in the spinal cord and the dorsal root ganglia of the chick embryo.
Anti-apogen antibodies labeled a sub-population of the profiles of dying cells in regions where cell death was occurring.
The extent of labeling by anti-apogens varied from 3% to 70% of the total number of dying profiles depending on the specific antibody used and the neuronal region examined. Immunoreactive labeling by the anti-engulfen antibodies mainly involved large cells that contained debris of dead cells.
These results indicate that at least some dying neuronal cells express common antigens that are shared by dying mesenchymal cells during programmed cell death, and that phagocytotic cells of the immune system are involved in the engulf ment of neuronal cells that have undergone programmed cell death.
Although recent studies have identified two molecular families, Bcl-2 and interleukin-1R converting enzyme, as being involved in the process of programmed cell death in vertebrates (BOISE et al., 1993; MIURA et al., 1993; OLTVAI et al., 1993) , most components of the pathway leading to this type of cell death in vertebrates remain to be identified. One possible approach to address this issue is to generate markers that recognize molecules specifically expressed in cells undergoing programmed cell death. Using this approach, monoclonal antibodies have been generated (RDTELLO et al., 1994 ) that detect either dying cells (anti-apogens) or engulfment cells which contain apoptotic cells and apoptotic bodies (anti-engulfens) in various regions of embryos undergoing programmed cell death, indicating that the death processes of diverse cells during embryonic development may share a common mechanism. However, because the labeled neuronal cells were far fewer than previously indicated based on conventional staining, it is uncertain whether the antigens recognized by anti-apogens and anti-engulfens are expressed on all or even most dying neuronal cells (RoTELLO et al., 1994) .
To investigate this problem, we have systematically examined the expression of antigens detected by anti-apogen and anti-engulfen antibodies in the spinal cord and dorsal root ganglia of the chick embryo, sites where various types of programmed cell death are known to occur at different developmental stages (LEVI-MONTALTINI, 1950; HAMBURGER, 1975; HAMBURGER et al., 1981; HoMMA et al., 1994; YAGINUMA et al., submitted) .
MATERIALS AND METHODS
Monoclonal antibodies, (anti-apogens and anti-engulfens) that recognize dying cells or cells that engulf dead cells were raised using the immunosuppression method as described previously (ROTELLO et al., 1994 Among these antibodies, five clones (R2/I, R6/I, R7/ I, R15A/II, R15F/II) were examined in this study. Fertilized chicken eggs were obtained from Daiichi farm (Akagi, Gunma, Japan). The eggs were incubated in the laboratory(37.6C, 60% humidity) until the desired stages. On embryonic day (E) 3, E4. 5, E6 and E7. 5, chick embryos were fixed overnight by immersion in 4% paraf ormaldehyde in 0.1M phosphate buffer containing 3% sucrose. The brachial region of E3 embryos, the cervical and brachial regions of E4.5 embryos, the thoracic region of E6 embryos and the lumbar region of E7.5 embryos were removed and cryoprotected in 30% sucrose in phosphate buffer. Tissues were embedded in an OCT compound and quick-frozen in dry ice and isopentane. Frozen sections were cut at 5-10um and collected on silanecoated slides.
Intrinsic peroxidase activity was blocked with 0.3% H2O2 for 30min. Non-specific sites on the sections were blocked with 2% normal goat serum for 30min. Primary antibodies, the supernatant of hybridomas, undiluted or diluted by PBS at 1: 2-8, were incubated overnight at 4C. After washing with PBS, biotin labeled anti-mouse IgG (for R7/I, R15A/II, R15F/II) or anti-mouse IgM (for R2/I, R6/I) was applied. Immunoreactivity was localized using either an ABC elite kit (Vector) or streptavidine-FITC conjugate. DAB was used as the chromogen for peroxidase reaction.
Apoptotic cells were also visualized by the TUNEL method (Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin Nick End Labeling method) described by GAVRIELI et al. (1992) . For double-staining with anti-engulfen immunohistochemistry and TUNEL, a reaction solution composed of 1mM of CoC12 50ug/ml of gelatin, 10nmol/ml of biotin-l6-dUTP (Boehringer Mannheim-Yamanouchi), 100U/ml of terminal deoxynucleotidyl transferase (Takara Shuzou) and 100mM of Sodium Cacodylate buffer (pH7.0), was applied to the sections following immunohistochemisitry.
Streptavidin-Texas
Red conjugate was used for detecting incorporated biotin-l6-dUTP by the TUNEL reaction. Observations were made with a Zeiss Axiophot microscope with Nomarski optics or with a Leica TCM 4D conf ocal microscope.
RESULTS AND DISCUSSION
The distribution of the immunoreactivity of antiapogen antibodies (R2/I, R6/I, R7/I) was examined in the brachial neural tube on E3, the cervical ventral horn on E4.5, the lumbar lateral motor column on E7. 5 and the thoracic dorsal root ganglia on E6, all sites where many cells reported by undergo cell death (Fig.  1A -D, F-I, K-N). Sections containing dying mesenchymal tissue beneath the apical epidermal ridge of the wing bud were stained with anti-apogens as a positive control (Fig. 1E, J, 0) . We confirmed that cell death actually occurred at all these sites and ages by staining neighboring sections with TUNEL method (Fig. 1P-T) .
Immunoreactivity was found in all neuronal regions and mesenchymal tissue following the staining with R2/I, R6/I and R7/I antibodies (Fig. 1A-O) . Dying cells could be recognized as rounded profiles by Nomarski optics. The location and occurrence of immunopositive profiles were consistent with the presence of these round pyknotic cell profiles (Fig. 1A-O) . However, observations with Nomarski optics also revealed that there were many dying profiles which were not immunoreactive to R2/I, R6/I or R7/I antibodies (Fig.  1B, G, L) .
To quantify the ratio of Immunoreactivity in each region, we counted immunopositive and TUNEL positive profiles in the cervical ventral horn, the thoracic dorsal root ganglia and the lumbar lateral motor column (Table 1) . Only profiles whose diameter exceeded 2. 5 um were counted. The ratio of immunopositive dying profiles versus TUNEL positive profiles varied with each antibody and region examined. The R2/I and R6/I antibodies exhibited a similar ratio of immunoreactive and TUNEL labeled elements in all regions examined. The number of immunopositive profiles stained by these antibodies was only 3-6% of the total number of dying profiles in the cervical ventral horn at E4.5, whereas they stained approximately 40% of the total number of dying profiles in the lumbar lateral motor column at E7.5, and 12 to 20% in the dorsal root ganglia at E6. By contrast, approximately 70% of the total number of dying profiles were stained with the R7/I antibody in the E4.5 cervical ventral horn (Table 1) . The R7/I antibody also recognized apoptotic profiles smaller than 2.5um (Fig. 1L) . The ratios of immunopositive profiles labeled with R7/I in the lumbar lateral motor column at E7. 5 and the dorsal root ganglia at E6 were approximately 70% and 30%, respectively, of the dying profiles identified by the TUNEL method.
Labeling by the anti-engulfen antibodies (R15A/II and R15F/II) was also recognized in neuronal tissue. Double staining with the TUNEL method revealed that dying cells or debris were contained within large, irregular or round shaped cells that were labeled by the anti-engulfen antibodies (Fig. 2) . Endothelial cells of blood vessels were also labeled by these antibodies (Fig. 2E asterisk) . Although it has been known that, in the nervous system, adjacent neuroepithelial cells may participate in engulfing or phagocytosing apoptotic cells (GARCIA-PORRERO and OJEDA, 1979; SILVER et al., 1987; CUADROS and Rios, 1988; HOMMA et al., 1994; YAGINUMA et al., submitted) , neuroepithelial cells, identified by their elongated shape, and which extended between the central canal and the outer limiting membrane, were not stained with the anti-engulfen antibodies.
In a previous study, the number of the cells labeled with these antibodies was far less than expected based on the known rates of programmed cell death in the nervous system. Therefore, it was not clear whether the antigens that are recognized by antiapogen antibodies are also expressed by dying cells in the nervous system (ROTELLO et al., 1994) . The results of the present study clearly demonstrate that, in fact, these antigens are expressed in dying neuronal cells although they may not be expressed by all dying cells, or they may only be expressed during a limited part of the process of cell death. Our quantitative analysis revealed that the ratio of immunoreactivity of R2/I and R6/I differs from that of R7/I when examined in the same neuronal regions. Furthermore, the immunopositive profiles labeled by R7/I tended to be smaller than those labeled by R2/ I and R6/I. Although the antigens recognized by these antibodies remain to be identified, these differences suggest that the antigens recognized by R7/I are different from those recognized by R2/I and R6/I.
Although motoneurons that undergo cell death in the cervical ventral horn at E4.5 (YAGINUMA et al., submitted) and in the lumbar lateral motor column at E7.5 (HAMBURGER, 1975) exhibit similar apoptotic morphologies (O'CONNER and WYTTENBACH, 1974; CHU-WANG and OPPENHEIM, 1978; CLARKE, 1990) , ratios of the cells labeled by R2/I and R6/I were considerably lower in the cervical ventral horn. One possible explanation for this difference is that the antigens recognized by R2/I and R6/I are only expressed by dying motoneurons that are more advanced in their differentiation.
Alternatively, this may reflect fundamental differences in the nature of cell death pathways in the two types of motoneurons. In fact, we have reported that the regulation of motoneuron death in the E4.5 cervical ventral horn is different from that of motoneuron death in the E7.5 lumbar lateral motor column. In the lumbar lateral motor column, the survival of motoneurons is contingent on successfully competing for target-derived sources of trophic support (OPPENHEIM, 1989 (OPPENHEIM, , 1991 , whereas motoneuron death in the cervical ventral horn at E4.5 is independent of the regulation by targetderived signals (YAGINUMA et al., submitted) .
The present study has also demonstrated that the cells recognized by R15A/II and R15F/II antibodies (engulfens) are involved in the phagocytosis of apoptotic cells in the nervous system. It has previously been shown that R15A/II and R15F/II recognize phagocytotic mesenchymal cells in the interdigits that express a common leukocyte antigen, HIS-C7 (ROTELLO et al., 1994) . This suggests that cells in the immune system are involved in engulfing apoptotic cells in both the nervous and mesenchymal tissues. This is consistent with previous reports that macrophage-like phagocytotic cells are present in regions undergoing programmed neuronal death and that these are involved in engulfing apoptotic cells in the developing nervous system (CHU-WANG and OPPENHEIM, 1978; CUADROS et al., 1991; HOMMA et al., 1994; YAGINUMA et al., submitted) . Recent studies have reported that these macrophage-like cells are derived from the extraembryonic yolk sac (MARTIN-PARTIDO et al., 1991; CUADROS et al., 1991 CUADROS et al., , 1993 .
In summary, we have found that many cells undergoing programmed cell death in the nervous system of the chick embryo are labeled by antibodies that recognize apoptotic cells in other developing tissues. In addition, antibodies that recognize antigens of phagocytec engulf ment cells also label cells of the same nature function in the nervous system.
